You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-EPH Receptor A2 (EPHA2) Antibodies

Full name:
anti-EPH Receptor A2 Antibodies (EPHA2)
On are 312 EPH Receptor A2 (EPHA2) Antibodies from 31 different suppliers available. Additionally we are shipping EPH Receptor A2 Proteins (16) and EPH Receptor A2 Kits (5) and many more products for this protein. A total of 356 EPH Receptor A2 products are currently listed.
ARCC2, AW545284, CTPA, CTPP1, CTRCT6, Eck, epha2, MGC89505, Myk2, Sek-2, Sek2
list all antibodies Gene Name GeneID UniProt
EPHA2 1969 P29317
EPHA2 13836 Q03145
EPHA2 366492  

Show all species

Show all synonyms

Most Popular Reactivities for anti-EPH Receptor A2 (EPHA2) Antibodies

Select your species and application

anti-Human EPH Receptor A2 Antibodies:

anti-Mouse (Murine) EPH Receptor A2 Antibodies:

anti-Rat (Rattus) EPH Receptor A2 Antibodies:

All available anti-EPH Receptor A2 Antibodies

Go to our pre-filtered search.

Top referenced anti-EPH Receptor A2 Antibodies

  1. Human Monoclonal EPH Receptor A2 Primary Antibody for FACS, ICC - ABIN4899912 : Liao-Chan, Daine-Matsuoka, Heald, Wong, Lin, Cai, Lai, DAlessio, Theunissen: Quantitative assessment of antibody internalization with novel monoclonal antibodies against Alexa fluorophores. in PLoS ONE 2015 (PubMed)
    Show all 3 references for ABIN4899912

  2. Mouse (Murine) Monoclonal EPH Receptor A2 Primary Antibody for FACS, WB - ABIN4899679 : De Robertis, Loiacono, Fusilli, Poeta, Mazza, Sanchez, Marchionni, Signori, Lamorte, Vescovi, Garcia-Foncillas, Fazio: Dysregulation of EGFR Pathway in EphA2 Cell Subpopulation Significantly Associates with Poor Prognosis in Colorectal Cancer. in Clinical cancer research : an official journal of the American Association for Cancer Research 2016 (PubMed)
    Show all 3 references for ABIN4899679

  3. Human Polyclonal EPH Receptor A2 Primary Antibody for FACS, IHC - ABIN4899913 : Gopal, Bohonowych, Lema-Tome, Liu, Garrett-Mayer, Wang, Isaacs: A novel extracellular Hsp90 mediated co-receptor function for LRP1 regulates EphA2 dependent glioblastoma cell invasion. in PLoS ONE 2011 (PubMed)
    Show all 3 references for ABIN4899913

  4. Human Monoclonal EPH Receptor A2 Primary Antibody for EIA, IHC (p) - ABIN317512 : Ireton, Chen: EphA2 receptor tyrosine kinase as a promising target for cancer therapeutics. in Current cancer drug targets 2005 (PubMed)
    Show all 2 references for ABIN317512

  5. Human Polyclonal EPH Receptor A2 Primary Antibody for IF (p), IHC (p) - ABIN669201 : Wu, Fu, Zhou, Gong, Liu, Qiao, Li: HIF-1? and HIF-2?: siblings in promoting angiogenesis of residual hepatocellular carcinoma after high-intensity focused ultrasound ablation. in PLoS ONE 2014 (PubMed)

  6. Hamster Polyclonal EPH Receptor A2 Primary Antibody for EIA, IHC (p) - ABIN359790 : Lindberg, Hunter: cDNA cloning and characterization of eck, an epithelial cell receptor protein-tyrosine kinase in the eph/elk family of protein kinases. in Molecular and cellular biology 1991 (PubMed)

  7. Human Polyclonal EPH Receptor A2 Primary Antibody for DB, WB - ABIN650858 : Zhuang, Brantley-Sieders, Vaught, Yu, Xie, Wells, Jackson, Muraoka-Cook, Arteaga, Chen: Elevation of receptor tyrosine kinase EphA2 mediates resistance to trastuzumab therapy. in Cancer research 2010 (PubMed)

More Antibodies against EPH Receptor A2 Interaction Partners

Human EPH Receptor A2 (EPHA2) interaction partners

  1. EphA2, a member of the large family of Ephrin receptor tyrosine kinases, is a functional signaling receptor for progranulin (show GRN Antibodies).

  2. EphA2 have the ability to negatively regulate the radiosensitivity of HCC (show FAM126A Antibodies) 97H cells, which mainly depends on 38MAPK-mediated signal pathways.

  3. both EphA2 and EphB4 (show EPHB4 Antibodies) show potential as target for image-guided colorectal cancer surgery, but EphB4 (show EPHB4 Antibodies) seems to have the best characteristics with respect to tumor/normal mucosa distribution

  4. EphA2 is a key downstream target of the MEK (show MAP2K1 Antibodies)/ERK (show EPHB2 Antibodies)/RSK (show RPS6KA1 Antibodies) signaling pathway in the regulation of glioblastoma cell proliferation.

  5. possible involvement of membrane-type 1 matrix metalloproteinase (show MMP14 Antibodies) processing of erythropoietin (show EPO Antibodies)-producing hepatocellular receptor-2in invasiveness of cutaneous cutaneous squamous cell carcinoma

  6. cells with Lipoplatin. The combined effects of siRNA-EphA2 and Lipoplatin were determined. We report that silencing EphA2 significantly enhanced the cellular sensitivity of lung tumor and MPM cells to Lipoplatin and maybe a potential therapy for lung cancer.

  7. Data show that the EphA2 ectodomain harbors a membrane-binding motif in the FN2 (show FN1 Antibodies) domain which preferentially interacts with anionic lipids.

  8. Data show that microRNA miR (show MLXIP Antibodies)-141 is down-regulated in hepatocellular carcinoma (HCC (show FAM126A Antibodies)) tissues and it is negatively correlated with erythropoietin (show EPO Antibodies)-producing hepatocellular receptor A2 (EphA2) expression.

  9. Nuclear expression of EphA2 in this series of large tumours was significantly associated with an increased rate of metastasis. On the other hand, cytoplasmic localisation was associated with a better prognosis. As there was no correlation between EphA2 expression and angiogenesis, the mature vasculature or VM, EphA2 appears to become less important in the advanced stages of the disease.

  10. These data suggest that miR (show MLXIP Antibodies)-26b enhances the radiosensitivity of 97H hepatocellular cancer cells by targeting EphA2 protein.

Mouse (Murine) EPH Receptor A2 (EPHA2) interaction partners

  1. modulation of EphA2 signaling might contribute to effective transplantation of tissue-specific resident macrophages and/or monocytes

  2. Our data suggest that EphA2 is closely related to the formation of osteoblasts and resorption of osteoclast and is likely to play an role in bone resorption induced in chronic periodontitis

  3. We examined the roles of ephrin-A2 (show EFNA2 Antibodies) and ephrin-A5 (show EFNA5 Antibodies) signaling in contralateral targeting and topographic ordering in the ventral cochlear nucleus

  4. EphA2 acts as a KRas cooperative tumor suppressor

  5. Data shows that modulation of angiostatic factor Slit2 by EphA2 receptor regulates endothelial responses to VEGF-mediated angiogenesis and tumor neovascularization.

  6. Sporozoites productively infected hepatocytes with high EphA2 expression, and the deletion of EphA2 protected mice from liver infection.

  7. EphA2-mutant mice are more prone to hyperglycemia-induced increased injury and decreased survival.

  8. EphA2 receptor silencing attenuates the extent and inflammation of atherosclerotic lesions in ApoE (show APOE Antibodies)(-/-) mice.

  9. these data demonstrate a role for EPHA2 in the maintenance and progression of NSCLCs and provide evidence that ALW-II-41-27 effectively inhibits EPHA2-mediated tumor growth in preclinical models of NSCLC.

  10. These results indicate that EphA2/Src signaling is essential for the formation of the lens fulcrum. EphA2 also regulates Src/cortactin/F-actin complexes at the vertices of hexagonal equatorial cells for cell-to-cell alignment.

Cow (Bovine) EPH Receptor A2 (EPHA2) interaction partners

  1. The present study successfully assessed the expression pattern of miR26b in the pituitary tissue of Yanbian cattle, and also confirmed that EphA2 was a target gene of miR26b in Yanbian cattle in vitro.

EPH Receptor A2 (EPHA2) Antigen Profile

Antigen Summary

This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. This gene encodes a protein that binds ephrin-A ligands. Mutations in this gene are the cause of certain genetically-related cataract disorders.

Alternative names and synonyms associated with EPH Receptor A2 (EPHA2)

  • EPH receptor A2 (EPHA2) antibody
  • EphA2 (epha2) antibody
  • epoxide hydrolase (ephA2) antibody
  • Eph receptor A2 (Epha2) antibody
  • ARCC2 antibody
  • AW545284 antibody
  • CTPA antibody
  • CTPP1 antibody
  • CTRCT6 antibody
  • Eck antibody
  • epha2 antibody
  • MGC89505 antibody
  • Myk2 antibody
  • Sek-2 antibody
  • Sek2 antibody

Protein level used designations for anti-EPH Receptor A2 (EPHA2) Antibodies

EPH receptor A2 , protein tyrosine kinase EphA2 , EphA2 , ephrin receptor EphA2 , ephrin type-A receptor 2 , epoxide hydrolase , epithelial cell receptor protein tyrosine kinase , soluble EPHA2 variant 1 , tyrosine-protein kinase receptor ECK , epithelial cell kinase , tyrosine-protein kinase receptor MPK-5 , tyrosine-protein kinase receptor SEK-2

100053644 Equus caballus
395311 Gallus gallus
448450 Xenopus (Silurana) tropicalis
456472 Pan troglodytes
692343 Macaca mulatta
1214785 Streptomyces avermitilis MA-4680
100591506 Nomascus leucogenys
1969 Homo sapiens
13836 Mus musculus
366492 Rattus norvegicus
487421 Canis lupus familiaris
512798 Bos taurus
771550 Gallus gallus
Selected quality suppliers for anti-EPH Receptor A2 (EPHA2) Antibodies
Did you look for something else?